z-logo
open-access-imgOpen Access
Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
Author(s) -
Junrong Chen,
Lei Mai,
Jiachen Sun,
Xiang Peng,
Min Zhang,
Min Zhi
Publication year - 2022
Publication title -
gastroenterology report
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 26
eISSN - 2052-0034
pISSN - 2304-1412
DOI - 10.1093/gastro/goac032
Subject(s) - medicine , mesalazine , ulcerative colitis , refractory (planetary science) , thalidomide , gastroenterology , adverse effect , pharmacology , disease , physics , astrobiology , multiple myeloma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom